Women's Health Market Report 2026

Women's Health Market Overview

• Women's Health market size has reached to $45.36 billion in 2025 • Expected to grow to $60.99 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Surge In Women-Centric Diseases To Propel The Women's Health Market • Market Trend: Technological Advancement In Women's Health For Menstrual Pain Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Women's Health Market?

Women's health refers to the branch of medicine and healthcare that focuses on the diagnosis, treatment, and prevention of diseases and conditions that specifically affect women. It encompasses a wide range of issues including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions such as breast and ovarian cancers. It also addresses other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders. The main types of products for women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are the devices that are used to cure medical diseases of women. Women aged 50 years and older and others undergo hormonal treatment, non-hormonal treatment, and surgeries for various applications, including postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, and polycystic ovary syndrome (PCOS), through various distribution channels such as hospitals, retail stores, and online pharmacies.

What Is The Women's Health Market Growth Forecast?

The women's health market size is expected to see strong growth in the next few years. It will grow to $60.99 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing investments in women-focused drug development, rising demand for personalized treatment plans, expansion of early screening programs, growing adoption of digital health integration, increasing focus on long-term women’s health management. Major trends in the forecast period include increasing development of targeted therapies for women, rising adoption of precision medicine approaches, growing use of advanced diagnostic tools, expansion of non-hormonal treatment options, enhanced focus on preventive women’s healthcare.

Global Women's Health Market Segmentation

1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline 2) By Age: 50 Years & above , Other Ages 3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries 4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis And Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS) 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps 2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives 3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

What Is The Driver Of The Women's Health Market?

The rising prevalence of women-centric diseases is expected to propel the growth of the women's health market going forward. The women-centric diseases such as anemia, osteoporosis, breast cancer, menopause, and others are highly occurring due to various risk factors such as family history, increasing age, early onset of periods or menopause after 55 years, obesity, and others. This rising prevalence of women-centric diseases drives demand for women's health products and services that are required to treat these diseases and ensure the health and wellness of women. For instance, American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer published an article in January 2023, according to which, cervical cancer was once one of the most common causes of cancer death for American women. About 13,960 new cases of invasive cervical cancer will be diagnosed in the USA in 2023 and from that around 4,310 women is expected to die from cervical cancer. Therefore, the rising prevalence of women-centric diseases is driving the growth of the women's health industry.

Key Players In The Global Women's Health Market

Major companies operating in the women's health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Maven Clinic Inc., MobileODT Ltd., ObsEva SA, Syrona Health AG.

Global Women's Health Market Trends and Insights

Major companies operating in the women’s health market are introducing new technologies to sustain their position in the market, such as the transcutaneous electrical nerve stimulation (TENS) technology. Transcutaneous Electrical Nerve Stimulation (TENS) technology is a non-invasive therapeutic technique that involves the use of a small, battery-operated device to deliver low-voltage electrical currents to specific areas of the body through electrode pads placed on the skin. For instance, in September 2023, Myoovi, a UK-based menstrual pain solutions provider launched a new technology, the transcutaneous electrical nerve stimulation (TENS) technology to manage painful menstruation cramps. TENS produces electrical signals that interfere with and block the pain signals that attempt to reach the brain. The instrument allows less pain by disrupting and blocking these pain signals. This new technology can help women tackle painful menstrual cramps with a drug-free alternative.

What Are Latest Mergers And Acquisitions In The Women's Health Market?

In March 2024, Halma, a UK-based technology company, acquired Rovers Medical Devices (Rovers) for $92.63 million. This acquisition broadens Halma's offerings in the women's health sector, particularly in cervical cancer diagnostics, aligning with its goal to strengthen its position in cancer diagnosis products. Rovers Medical Devices (Rovers) is a Netherlands-based company, specializes in the design and manufacture of sample collection devices aimed at diagnosing and preventing cervical cancer.

Regional Outlook

North America was the largest region in the women's health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the women's health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Women's Health Market?

The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynaecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and Class, among others, that are used in providing women's health services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Women's Health Market Report 2026?

The women's health market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.